The Discounted Cash Flow (DCF) valuation of BioPharma Credit PLC (BPCR.L) is 1.20 USD. With the latest stock price at 0.88 USD, the upside of BioPharma Credit PLC based on DCF is 35.5%.
Based on the latest price of 0.88 USD and our DCF valuation, BioPharma Credit PLC (BPCR.L) is a buy. buying BPCR.L stocks now will result in a potential gain of 35.5%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 10.1% | 8.9% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 1.02 - 1.47 | 1.20 |
| Upside | 14.8% - 66.8% | 35.5% |